ClinicalTrials.Veeva

Menu

Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation

N

Nanjing Children's Hospital

Status

Completed

Conditions

Lymphatic Malformation

Treatments

Procedure: ICGL-guided treatment
Procedure: Conventional Treatment group

Study type

Interventional

Funder types

Other

Identifiers

NCT06755905
NanjingCH0116651

Details and patient eligibility

About

To elucidate the application of indocyanine green (ICG) fluorescence angiography in the treatment of childhood tongue cLM (clinically localized malignancy, presumed context here), providing a clearer scientific basis for subsequent targeted interventions.

Enrollment

42 patients

Sex

All

Ages

Under 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • No previous intervention
  • more than 6 months post-treatment follow-up
  • Stage I or Stage IIa

Exclusion criteria

  • History of iodine allergy
  • Syndromic cLM
  • Severe liver and kidney dysfunction

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

42 participants in 2 patient groups

lingual LM with ICGL-guided treatment
Experimental group
Description:
indocyanine green lymphography guided resection combined with sclerotherapy
Treatment:
Procedure: ICGL-guided treatment
Conventional treatment
Active Comparator group
Description:
lingual LM with conventional treatment
Treatment:
Procedure: Conventional Treatment group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems